MedPath
TGA Approval

COMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection single dose vial (419370)

419370

COMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection single dose vial

Pfizer Australia Pty Ltd

December 22, 2023

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-02414-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-PI-02409-1

Active Ingredients

raxtozinameran

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

COMIRNATY Omicron XBB.1.5 (raxtozinameran) COVID-19 VACCINE 30 micrograms/0.3 mL suspension for injection single dose vial (419370) - TGA 批准文号 | MedPath